<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиотерапия, бальнеология и реабилитация</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1681-3456</issn><issn publication-format="electronic">2413-2969</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">630926</article-id><article-id pub-id-type="doi">10.17816/rjpbr630926</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Dynamics of markers of oxidative stress during the complex use of therapeutic physical factors in patients with true eczema associated with metabolic syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Динамика маркеров оксидативного стресса при комплексном применении лечебных физических факторов у больных истинной экземой, ассоциированной с метаболическим синдромом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5402-5009</contrib-id><contrib-id contrib-id-type="spin">7219-5306</contrib-id><name-alternatives><name xml:lang="en"><surname>Arutyunyan</surname><given-names>Emma E.</given-names></name><name xml:lang="ru"><surname>Арутюнян</surname><given-names>Эмма Эдуардовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dr.arutyunyan@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4260-1619</contrib-id><contrib-id contrib-id-type="spin">7673-3241</contrib-id><name-alternatives><name xml:lang="en"><surname>Mikhailova</surname><given-names>Anna A.</given-names></name><name xml:lang="ru"><surname>Михайлова</surname><given-names>Анна Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Associate Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доцент</p></bio><email>noc@med.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1190-1440</contrib-id><contrib-id contrib-id-type="spin">2099-3854</contrib-id><name-alternatives><name xml:lang="en"><surname>Nagornev</surname><given-names>Sergey N.</given-names></name><name xml:lang="ru"><surname>Нагорнев</surname><given-names>Сергей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>drnag@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">North-Ossetian State Medical Academy</institution></aff><aff><institution xml:lang="ru">Северо-Осетинская государственная медицинская академия</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Central state medical academy of department of presidential affairs</institution></aff><aff><institution xml:lang="ru">Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-09-20" publication-format="electronic"><day>20</day><month>09</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-02-20" publication-format="electronic"><day>20</day><month>02</month><year>2024</year></pub-date><volume>23</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>15</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2024-04-24"><day>24</day><month>04</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-09-07"><day>07</day><month>09</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder></permissions><self-uri xlink:href="https://rjpbr.com/1681-3456/article/view/630926">https://rjpbr.com/1681-3456/article/view/630926</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND:</italic></bold> Among various pathological conditions associated with true eczema, metabolic syndrome occupies a special place, the high social significance of which is determined by its dominant influence on the main demographic indicators — life expectancy and mortality of the population.</p> <p><bold><italic>AIM:</italic></bold><bold> </bold>Assessment of the dynamics of parameters of pro- and antioxidant systems in patients with true eczema in combination with metabolic syndrome during the course application of broadband medium-wave phototherapy, mesodiencephalic modulation and their combination.</p> <p><bold><italic>MATERIALS AND METHODS: </italic></bold>A prospective, controlled, comparative, randomized study was performed involving 115 patients with true eczema combined with metabolic syndrome, who were divided into 4 groups using simple randomization. The first group (control) received only basic drug therapy. In the second (comparison 1), third (comparison 2), and fourth (main) groups, patients additionally underwent courses of broadband medium-wave phototherapy, mesodiencephalic modulation, and their combination, respectively. The results of the course application of physiofactors were assessed by the dynamics of pro- and antioxidant system indices before and after the end of therapy.</p> <p><bold><italic>RESULTS:</italic></bold><bold> </bold>When comparing the main markers of oxidative stress between the group of healthy people and patients with true eczema in combination with metabolic syndrome, a pronounced imbalance in the "prooxidants-antioxidants" system was established, which indicates the development of oxidative stress. Conducting complex therapy had a corrective effect on the parameters of the lipid peroxidation process. More pronounced shifts in lipid peroxide metabolism indicators were revealed in the groups with the additional use of physiotherapeutic factors. The maximum corrective effect in relation to oxidative stress was established in the group with the complex use of physiofactors. An integrative assessment of the dynamics of oxidative stress markers using the antioxidant protection coefficient confirmed the results obtained.</p> <p><bold><italic>CONCLUSION: </italic></bold>The use of therapeutic physical factors in the therapy of true eczema and metabolic syndrome is largely based on their ability to act as redox regulators of intracellular processes, exhibiting a stress-limiting effect and restoring oxidation-reduction homeostasis. The most promising in this regard are broadband medium-wave phototherapy and mesodiencephalic modulation.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>Среди различных патологических состояний, ассоциированных с истинной экземой, особое место занимает метаболический синдром, высокая социальная значимость которого определяется его доминирующим влиянием на основные демографические показатели ― продолжительность жизни и смертность населения.</p> <p><bold>Цель исследования</bold> ― оценка динамики параметров про- и антиоксидантной систем у больных истинной экземой в сочетании с метаболическим синдромом при курсовом применении широкополосной средневолновой фототерапии, мезодиэнцефальной модуляции и их комбинации.</p> <p><bold>Материалы и методы.</bold> Выполнено проспективное контролируемое сравнительное рандомизированное исследование с участием 115 пациентов с истинной экземой в сочетании с метаболическим синдромом, которых с помощью простой фиксированной рандомизации разделили на 4 группы. Первая группа (контрольная, <italic>n</italic>=29) получала только базовую медикаментозную терапию. Во второй (сравнения 1, <italic>n</italic>=28), третьей (сравнения 2, <italic>n</italic>=29) и четвёртой (основная, <italic>n</italic>=29) группах пациентам наряду с базовой медикаментозной терапией проводили курс широкополосной средневолновой фототерапии, курс мезодиэнцефальной модуляции или курс комплексного воздействия фототерапии и мезодиэнцефальной модуляции соответственно. Результаты курсового применения физиофакторов оценивали по динамике показателей про- и антиоксидантной систем до и по окончании терапии.</p> <p><bold>Результаты. </bold>При сравнении основных маркеров оксидативного стресса между группой здоровых и больных истинной экземой в сочетании с метаболическим синдромом установлен выраженный дисбаланс в системе «прооксиданты-антиоксиданты», что свидетельствует о развитии оксидативного стресса. Проведение комплексной терапии оказывало корригирующее влияние на параметры процесса липопероксидации. Более выраженные сдвиги показателей липоперекисного метаболизма, по сравнению с контрольной группой, выявлены в группах с дополнительным использованием физиотерапевтических факторов, при этом биологический потенциал фототерапии преобладал над мезодиэнцефальной модуляцией, вызывая более выраженную позитивную динамику оцениваемых параметров. Максимальный корригирующий эффект в отношении оксидативного стресса выявлен в группе с комплексным использованием физиофакторов. Проведение интегративной оценки динамики маркеров оксидативного стресса с помощью коэффициента антиоксидантной защиты подтвердило полученные результаты.</p> <p><bold>Заключение. </bold>Применение лечебных физических факторов в терапии истинной экземы и метаболического синдрома во многом базируется на их способности выступать редокс-регуляторами внутриклеточных процессов, проявляя стресс-лимитирующее действие и восстанавливая окислительно-восстановительный гомеостаз. Наиболее перспективными в этом отношении выступают широкополосная средневолновая фототерапия и мезодиэнцефальная модуляция.</p></trans-abstract><kwd-group xml:lang="en"><kwd>phototherapy</kwd><kwd>mesodiencephalic modulation</kwd><kwd>true eczema</kwd><kwd>metabolic syndrome</kwd><kwd>oxidative stress</kwd><kwd>malondialdehyde</kwd><kwd>superoxide dismutase</kwd><kwd>catalase</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фототерапия</kwd><kwd>мезодиэнцефальная модуляция</kwd><kwd>истинная экзема</kwd><kwd>метаболический синдром</kwd><kwd>оксидативный стресс</kwd><kwd>малоновый диальдегид</kwd><kwd>супероксиддисмутаза</kwd><kwd>каталаза</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Brown SJ. Molecular mechanisms in atopic eczema: Insights gained from genetic studies. J Pathol. 2017;241(2):140–145. doi: 10.1002/path.4810</mixed-citation><mixed-citation xml:lang="ru">Brown S.J. Molecular mechanisms in atopic eczema: Insights gained from genetic studies // J Pathol. 2017. Vol. 241, N 2. P. 140–145. doi: 10.1002/path.4810</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Civelek E, Sahiner UM, Yüksel H, et al. Prevalence, burden, and risk factors of atopic eczema in schoolchildren aged 10-11 years: A national multicenter study. J Investig Allergol Clin Immunol. 2011;21(4):270–277.</mixed-citation><mixed-citation xml:lang="ru">Civelek E., Sahiner U.M., Yüksel H., et al. Prevalence, burden, and risk factors of atopic eczema in schoolchildren aged 10-11 years: A national multicenter study // J Investig Allergol Clin Immunol. 2011. Vol. 21, N 4. P. 270–277.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Conradi AO, Baranova EI, Gurevich VS, et al. Tactics of management of patients with cardiovascular diseases. Roundtable report. Consilium Medicum. 2021;23(6):504–510. EDN: UIIIWH doi: 10.26442/20751753.2021.6.200950</mixed-citation><mixed-citation xml:lang="ru">Конради А.О., Баранова Е.И., Гуревич В.С., и др. Тактика ведения пациентов с сердечно-сосудистыми заболеваниями. Отчет о проведении круглого стола // Consilium Medicum. 2021. Т. 23, № 6. С. 504–510. EDN: UIIIWH doi: 10.26442/20751753.2021.6.200950</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Li D, Wang L, Zhou Z, et al. Lifetime risk of cardiovascular disease and life expectancy with and without cardiovascular disease according to changes in metabolic syndrome status. Nutr Metab Cardiovasc Dis. 2022;32(2):373–381. doi: 10.1016/j.numecd.2021.10.014</mixed-citation><mixed-citation xml:lang="ru">Li D., Wang L., Zhou Z., et al. Lifetime risk of cardiovascular disease and life expectancy with and without cardiovascular disease according to changes in metabolic syndrome status // Nutr Metab Cardiovasc Dis. 2022. Vol. 32, N 2. P. 373–381. doi: 10.1016/j.numecd.2021.10.014</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Forman HJ, Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20(9):689–709. doi: 10.1038/s41573-021-00233-1</mixed-citation><mixed-citation xml:lang="ru">Forman H.J., Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy // Nat Rev Drug Discov. 2021. Vol. 20, N 9. P. 689–709. doi: 10.1038/s41573-021-00233-1</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Nagoev BS, Nalchikova MT. Features of lipid peroxidation in patients with eczema. Kuban Scientific Med Bull. 2012;(4):74–77. EDN: PVRDGR</mixed-citation><mixed-citation xml:lang="ru">Нагоев Б.С., Нальчикова М.Т. Особенности перекисного окисления липидов у больных экземой // Кубанский научный медицинский вестник. 2012. № 4. С. 74–77. EDN: PVRDGR</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Novikova LA, Dontsova EV, Chernov AV, et al. Features of cytokine status, lipid peroxidation and the state of the antioxidant system in patients with true eczema. Pharmateka. 2022;29(14):73–77. EDN: EXPIGA doi: 10.18565/pharmateca.2022.14.73-77</mixed-citation><mixed-citation xml:lang="ru">Новикова Л.А., Донцова Е.В., Чернов А.В., и др. Особенности цитокинового статуса, перекисного окисления липидов и состояния антиоксидантной системы у больных истинной экземой // Фарматека. 2022. Т. 29, № 14. С. 73–77. EDN: EXPIGA doi: 10.18565/pharmateca.2022.14.73-77</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Cordiano R, Di Gioacchino M, Mangifesta R, et al. Malondialdehyde as a potential oxidative stress marker for allergy-oriented diseases: An update. Molecules. 2023;28(16):5979. doi: 10.3390/molecules28165979</mixed-citation><mixed-citation xml:lang="ru">Cordiano R., Di Gioacchino M., Mangifesta R., et al. Malondialdehyde as a potential oxidative stress marker for allergy-oriented diseases: An update // Molecules. 2023. Vol. 28, N 16. P. 5979. doi: 10.3390/molecules28165979</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Amin MN, Liza KF, Sarwar MS, et al. Effect of lipid peroxidation, antioxidants, macro minerals and trace elements on eczema. Arch Dermatol Res. 2015;307(7):617–623. doi: 10.1007/s00403-015-1570-2</mixed-citation><mixed-citation xml:lang="ru">Amin M.N., Liza K.F., Sarwar M.S., et al. Effect of lipid peroxidation, antioxidants, macro minerals and trace elements on eczema // Arch Dermatol Res. 2015. Vol. 307, N 7. P. 617–623. doi: 10.1007/s00403-015-1570-2</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Yu Y, Liu S, Yang L, et al. Roles of reactive oxygen species in inflammation and cancer. Med Comm (2020). 2024;5(4):e519. doi: 10.1002/mco2.519</mixed-citation><mixed-citation xml:lang="ru">Yu Y., Liu S., Yang L., et al. Roles of reactive oxygen species in inflammation and cancer // Med Comm (2020). 2024. Vol. 5, N 4. P. e519. doi: 10.1002/mco2.519</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Lingappan K. NF-κB in oxidative stress. Curr Opin Toxicol. 2018;(7):81–86. doi: 10.1016/j.cotox.2017.11.002</mixed-citation><mixed-citation xml:lang="ru">Lingappan K. NF-κB in oxidative stress // Curr Opin Toxicol. 2018. Vol. 7. P. 81–86. doi: 10.1016/j.cotox.2017.11.002</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Iyer SS, Accardi CJ, Ziegler TR, et al. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One. 2009;4(3):e5017. doi: 10.1371/journal.pone.0005017</mixed-citation><mixed-citation xml:lang="ru">Iyer S.S., Accardi C.J., Ziegler T.R., et al. Cysteine redox potential determines pro-inflammatory IL-1beta levels // PLoS One. 2009. Vol. 4, N 3. P. e5017. doi: 10.1371/journal.pone.0005017</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Lei Y, Wang K, Deng L, et al. Redox regulation of inflammation: Old elements, a new story. Med Res Rev. 2015;35(2):306–340. doi: 10.1002/med.21330</mixed-citation><mixed-citation xml:lang="ru">Lei Y., Wang K., Deng L., et al. Redox regulation of inflammation: Old elements, a new story // Med Res Rev. 2015. Vol. 35, N 2. P. 306–340. doi: 10.1002/med.21330</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Monserrat-Mesquida M, Quetglas-Llabrés M, Capó X, et al. metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants (Basel). 2020;9(3):236. doi: 10.3390/antiox9030236</mixed-citation><mixed-citation xml:lang="ru">Monserrat-Mesquida M., Quetglas-Llabrés M., Capó X., et al. metabolic syndrome is associated with oxidative stress and proinflammatory state // Antioxidants (Basel). 2020. Vol. 9, N 3. P. 236. doi: 10.3390/antiox9030236</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Franco C, Sciatti E, Favero G, et al. Essential hypertension and oxidative stress: Novel future perspectives. Int J Mol Sci. 2022;23(22):14489. doi: 10.3390/ijms232214489</mixed-citation><mixed-citation xml:lang="ru">Franco C., Sciatti E., Favero G., et al. Essential hypertension and oxidative stress: Novel future perspectives // Int J Mol Sci. 2022. Vol. 23, N 22. P. 14489. doi: 10.3390/ijms232214489</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Hachiya R, Tanaka M, Itoh M, et al. Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome. Inflamm Regen. 2022;42(1):13. doi: 10.1186/s41232-022-00198-7</mixed-citation><mixed-citation xml:lang="ru">Hachiya R., Tanaka M., Itoh M., et al. Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome // Inflamm Regen. 2022. Vol. 42, N 1. P. 13. doi: 10.1186/s41232-022-00198-7</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Jakubczyk K, Dec K, Kałduńska J, et al. Reactive oxygen species: Sources, functions, oxidative damage. Pol Merkur Lekarski. 2020;48(284):124–127.</mixed-citation><mixed-citation xml:lang="ru">Jakubczyk K., Dec K., Kałduńska J., et al. Reactive oxygen species: Sources, functions, oxidative damage // Pol Merkur Lekarski. 2020. Vol. 48, N 284. P. 124–127.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Touyz RM, Rios FJ, Alves-Lopes R, et al. Oxidative stress: A unifying paradigm in hypertension. Can J Cardiol. 2020;36(5):659–670. doi: 10.1016/j.cjca.2020.02.081</mixed-citation><mixed-citation xml:lang="ru">Touyz R.M., Rios F.J., Alves-Lopes R., et al. Oxidative stress: A unifying paradigm in hypertension // Can J Cardiol. 2020. Vol. 36, N 5. P. 659–670. doi: 10.1016/j.cjca.2020.02.081</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Ulashchik VS. Active oxygen species, antioxidants, and the action of therapeutic physical factors. Problems Balneology, Physiotherapy Exercise Therapy. 2013;90(1):60–69. EDN: PYASAR</mixed-citation><mixed-citation xml:lang="ru">Улащик В.С. Активные формы кислорода, антиоксиданты и действие лечебных физических факторов // Вопросы курортологии, физиотерапии и лечебной физической культуры. 2013. Т. 90, № 1. С. 60–69. EDN: PYASAR</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Zalesskaya GA, Ulashchik VS. Molecular mechanisms of action of photohemotherapy (review). J Applied Spectroscopy. 2009;76(1):51–75. EDN: JVEMET</mixed-citation><mixed-citation xml:lang="ru">Залесская Г.А., Улащик В.С. Молекулярные механизмы действия фотогемотерапии (обзор) // Журнал прикладной спектроскопии. 2009. Т. 76, № 1. С. 51–75. EDN: JVEMET</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Rathod DG, Muneer H, Masood S. Phototherapy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.</mixed-citation><mixed-citation xml:lang="ru">Rathod D.G., Muneer H., Masood S. Phototherapy // StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Gornov SV, Shestopalov AE, Litvinenko AB, et al. The program of hardware correction of the neuropsychic state of highly qualified athletes using mesodiencephalic modulation. Russ J Environmental Rehab Med. 2022;(2):70–80. EDN: QZTTSN</mixed-citation><mixed-citation xml:lang="ru">Горнов С.В., Шестопалов А.Е., Литвиненко А.Б., и др. Программа аппаратной коррекции нервно-психического состояния спортсменов высокой квалификации с применением мезодиэнцефальной модуляции // Russian Journal of Environmental and Rehabilitation Medicine. 2022. № 2. С. 70–80. EDN: QZTTSN</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Yumashev AV. Fundamental principles and practical results of the prevention and treatment of distress using mesodiencephalic modulation. Azimut nauchnykh issledovanii: pedagogika i psikhologiya. 2017;6(4):376–379. EDN: YLVFTU</mixed-citation><mixed-citation xml:lang="ru">Юмашев А.В. Фундаментальные основы и практические результаты профилактики и лечения дистресса с помощью мезодиэнцефальной модуляции // Азимут научных исследований: педагогика и психология. 2017. Т. 6, № 4. С. 376–379. EDN: YLVFTU</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Romanenko KV, Borovaya OO, Ermilova NV. Transcranial mesodiencephalic modulation and prospects for its use in dermatovenereology. Torsuevskie chteniya. 2020;(3):22–25. EDN: KMWYKK</mixed-citation><mixed-citation xml:lang="ru">Романенко К.В., Боровая О.О., Ермилова Н.В., и др. Транскраниальная мезодиэнцефальная модуляция и перспективы ее использования в дерматовенерологии // Торсуевские чтения: научно-практический журнал по дерматологии, венерологии и косметологии. 2020. № 3. С. 22–25. EDN: KMWYKK</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Hanifin JM, Baghoomian W, Grinich E, et al. The eczema area and severity index: A practical guide. Dermatitis. 2022;33(3):187–192. doi: 10.1097/DER.0000000000000895</mixed-citation><mixed-citation xml:lang="ru">Hanifin J.M., Baghoomian W., Grinich E., et al. The eczema area and severity index: A practical guide // Dermatitis. 2022. Vol. 33, N 3. P. 187–192. doi: 10.1097/DER.0000000000000895</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Recommendations for the management of patients with metabolic syndrome: Clinical guidelines. Moscow; 2013. 43 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Клинические рекомендации. Рекомендации по ведению больных с метаболическим синдромом. Москва, 2013. 43 с.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Clinical guidelines: Eczema. Moscow: Russian Society of Dermatovenerologists and Cosmetologists; 2021. 60 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Клинические рекомендации. Экзема. Москва: Российское общество дерматовенерологов и косметологов, 2021. 60 с.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Gavrilov VB, Gavrilova AR, Mazhul LM. Analysis of methods for determination of lipid peroxidation products in serum by thiobarbituric acid test. Voprosy medicinskoj himii. 1987;33(1):118–122. (In Russ.) EDN: SMPWZH</mixed-citation><mixed-citation xml:lang="ru">Гаврилов В.Б., Гаврилова А.Р., Мажуль Л.М. Анализ методов определения продуктов перекисного определения липидов в сыворотке крови по тесту с тиобарбитуровой кислотой // Вопросы медицинской химии. 1987. Т. 33, № 1. С. 118–122. EDN: SMPWZH</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Volchegorsky IA, Nalimov AG, Yarovinsky BG, et al. Comparison of different approaches to the determination of lipid peroxidation products in heptanisopropanol extracts of blood. Voprosy medicinskoj himii. 1989;35(1):127–131. (In Russ.) EDN: SKGMSF</mixed-citation><mixed-citation xml:lang="ru">Волчегорский И.А., Налимов А.Г., Яровинский Б.Г., и др. Сопоставление различных подходов к определению продуктов перекисного определения липидов в гептанизопропанольных экстрактах крови // Вопросы медицинской химии. 1989. Т. 35, № 1. С. 127–131. EDN: SKGMSF</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Umnyagina IA, Strakhova LA, Blinova TV. Serum of 8-OHDG as a potential biomarker of oxidative dna damage in workers exposed to harmful working environments. Russ J Occupational Health Industrial Ecology. 2019;59(9):783–784. EDN: OEPPZZ doi: 10.31089/1026-9428-2019-59-9-783-784</mixed-citation><mixed-citation xml:lang="ru">Умнягина И.А., Страхова Л.А., Блинова Т.В. Сывороточный 8-OHdG как потенциальный биомаркер окислительного повреждения ДНК у работающих во вредных условиях труда // Медицина труда и промышленная экология. 2019. Т. 59, № 9. С. 783–784. EDN: OEPPZZ doi: 10.31089/1026-9428-2019-59-9-783-784</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Korolyuk MA, Ivanova LI, Mayorova IG, Tokarev VE. Method for determination of catalase activity. Laboratornoe delo. 1988;(1):16–19. EDN: SICXEJ</mixed-citation><mixed-citation xml:lang="ru">Королюк М.А., Иванова Л.И., Майорова И.Г., Токарев В.Е. Метод определения активности каталазы // Лабораторное дело. 1988. № 1. С. 16–19. EDN: SICXEJ</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Kostyuk VA, Potapovich AI, Kovaleva ZhI. A simple and sensitive method of determination of superoxide dismutase activity based on the reaction of quercetin oxidation. Voprosy medicinskoj himii. 1990;36(2):88–91. EDN: SCXIZD</mixed-citation><mixed-citation xml:lang="ru">Костюк В.А., Потапович А.И., Ковалева Ж.И. Простой и чувствительный метод определения супероксиддисмутазы, основанный на реакции окисления кверцитина // Вопросы медицинской химии. 1990. Т. 36, № 2. С. 88–91. EDN: SCXIZD</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Sharifi-Rad M, Anil Kumar NV, Zucca P, et al. Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 2020;11:694. doi: 10.3389/fphys.2020.00694</mixed-citation><mixed-citation xml:lang="ru">Sharifi-Rad M., Anil Kumar N.V., Zucca P., et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases // Front Physiol. 2020. Vol. 11. P. 694. doi: 10.3389/fphys.2020.00694</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Raimondo A, Serio B, Lembo S. Oxidative stress in atopic dermatitis and possible biomarkers: Present and future. Indian J Dermatol. 2023;68(6):657–660. doi: 10.4103/ijd.ijd_878_22</mixed-citation><mixed-citation xml:lang="ru">Raimondo A., Serio B., Lembo S. Oxidative stress in atopic dermatitis and possible biomarkers: Present and future // Indian J Dermatol. 2023. Vol. 68, N 6. P. 657–660. doi: 10.4103/ijd.ijd_878_22</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Sies H. Oxidative eustress: On constant alert for redox homeostasis. Redox Biol. 2021;41:101867. doi: 10.1016/j.redox.2021.101867</mixed-citation><mixed-citation xml:lang="ru">Sies H. Oxidative eustress: On constant alert for redox homeostasis // Redox Biol. 2021. Vol. 41. P. 101867. doi: 10.1016/j.redox.2021.101867</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Nagornev SN, Sytnik SI, Bobrovnitsky IP, et al. Pharmacological correction of lipoperoxidation in hypoxia and the possibility of increasing human altitude tolerance with the help of drugs of metabolic type of action. Ann Russ Acad Med Sci. 1996;(7):53–60. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Нагорнев С.Н., Сытник С.И., Бобровницкий И.П., и др. Фармакологическая коррекция процесса липопероксидации при гипоксии и возможность повышения высотной устойчивости человека с помощью препаратов метаболического типа действия // Вестник РАМН. 1996. № 7. С. 53–60.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Liu J, Han X, Zhang T, et al. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: From mechanism to therapy. J Hematol Oncol. 2023;16(1):116. doi: 10.1186/s13045-023-01512-7</mixed-citation><mixed-citation xml:lang="ru">Liu J., Han X., Zhang T., et al. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: From mechanism to therapy // J Hematol Oncol. 2023. Vol. 16, N 1. P. 116. doi: 10.1186/s13045-023-01512-7</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23</mixed-citation><mixed-citation xml:lang="ru">Liu T., Zhang L., Joo D., et al. NF-κB signaling in inflammation // Signal Transduct Target Ther. 2017. Vol. 2. P. 17023. doi: 10.1038/sigtrans.2017.23</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Dominic A, Le NT, Takahashi M. Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal. 2022;36(10-12):784–796. doi: 10.1089/ars.2020.8257</mixed-citation><mixed-citation xml:lang="ru">Dominic A., Le N.T., Takahashi M. Loop between NLRP3 inflammasome and reactive oxygen species // Antioxid Redox Signal. 2022. Vol. 36, N 10-12. P. 784–796. doi: 10.1089/ars.2020.8257</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Lu Y, Wang M, Bao J, et al. Association between oxidative balance score and metabolic syndrome and its components in US adults: A cross-sectional study from NHANES 2011–2018. Front Nutr. 2024;13(11):1375060. doi: 10.3389/fnut.2024.1375060</mixed-citation><mixed-citation xml:lang="ru">Lu Y., Wang M., Bao J., et al. Association between oxidative balance score and metabolic syndrome and its components in US adults: A cross-sectional study from NHANES 2011–2018 // Front Nutr. 2024. Vol. 13, N 11. P. 1375060. doi: 10.3389/fnut.2024.1375060</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Nono Nankam PA, Nguelefack TB, Goedecke JH, et al. Contribution of adipose tissue oxidative stress to obesity-associated diabetes risk and ethnic differences: Focus on women of African ancestry. Antioxidants (Basel). 2021;10(4):622. doi: 10.3390/antiox10040622</mixed-citation><mixed-citation xml:lang="ru">Nono Nankam P.A., Nguelefack T.B., Goedecke J.H., et al. Contribution of adipose tissue oxidative stress to obesity-associated diabetes risk and ethnic differences: Focus on women of African ancestry // Antioxidants (Basel). 2021. Vol. 10, N 4. P. 622. doi: 10.3390/antiox10040622</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Čolak E, Pap D. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. J Med Biochem. 2021;40(1):1–9. doi: 10.5937/jomb0-24652</mixed-citation><mixed-citation xml:lang="ru">Čolak E., Pap D. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders // J Med Biochem. 2021. Vol. 40, N 1. P. 1–9. doi: 10.5937/jomb0-24652</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Nakai K, Yoneda K, Kubota Y. Oxidative stress in allergic and irritant dermatitis: From basic research to clinical management. Recent Pat Inflamm Allergy Drug Discov. 2012;6(3):202–209. doi: 10.2174/187221312802652839</mixed-citation><mixed-citation xml:lang="ru">Nakai K., Yoneda K., Kubota Y. Oxidative stress in allergic and irritant dermatitis: From basic research to clinical management // Recent Pat Inflamm Allergy Drug Discov. 2012. Vol. 6, N 3. P. 202–209. doi: 10.2174/187221312802652839</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Chen PY, Chen CW, Su YJ, et al. Associations between levels of urinary oxidative stress of 8-OHdG and risk of atopic diseases in children. Int J Environ Res Public Health. 2020;17(21):8207. doi: 10.3390/ijerph17218207</mixed-citation><mixed-citation xml:lang="ru">Chen P.Y., Chen C.W., Su Y.J., et al. Associations between levels of urinary oxidative stress of 8-OHdG and risk of atopic diseases in children // Int J Environ Res Public Health. 2020. Vol. 17, N 21. P. 8207. doi: 10.3390/ijerph17218207</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Kotenko KV, Frolkov VK, Nagornev SN, et al. Prospects for the use of drinking mineral waters in the rehabilitation of patients with coronavirus (COVID-19) infection: Analysis of the main sanogenetic mechanisms. Problems Balneology, Physiotherapy Exercise Therapy. 2021;98(6-2):75–84. EDN: RDBRST doi: 10.17116/kurort20219806275</mixed-citation><mixed-citation xml:lang="ru">Котенко К.В., Фролков В.К., Нагорнев С.Н., и др. Перспективы применения питьевых минеральных вод в реабилитации пациентов с коронавирусной (COVID-19) инфекцией: анализ основных саногенетических механизмов // Вопросы курортологии, физиотерапии и лечебной физической культуры. 2021. Т. 98, № 6-2. С. 75–84. EDN: RDBRST doi: 10.17116/kurort20219806275</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Petrova MS, Ruzova TK, Kotenko KV, Korchazhkina NB. Dynamics of metabolic exchange and circulation after lower limb traction elongaton in patients with lumbosacral dorsopathies. Physiotherapist. 2013;(6):25–30. EDN: RKPOQH</mixed-citation><mixed-citation xml:lang="ru">Петрова М.С., Рузова Т.К., Котенко К.В., Корчажкина Н.Б. Динамика показателей метаболического обмена и состояния кровообращения нижних конечностей после проведения тракционного вытяжения у пациентов с пояснично-крестцовыми дорсопатиями // Физиотерапевт. 2013. № 6. С. 25–30. EDN: RKPOQH</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Orekhova EM, Konchugova TV, Kulchitskaya DB, et al. Modern approaches to the use of transcerebral magnetic therapy for arterial hypertension. Problems Balneology, Physiotherapy Exercise Therapy. 2016;93(3):53–55. EDN: VZLSJFdoi: 10.17116/kurort2016353-55</mixed-citation><mixed-citation xml:lang="ru">Орехова Э.М., Кончугова Т.В., Кульчицкая Д.Б., и др. Современные подходы к применению трансцеребральной магнитотерапии при артериальной гипертензии // Вопросы курортологии, физиотерапии и лечебной физической культуры. 2016. Т. 93, № 3. С. 53–55. EDN: VZLSJF doi: 10.17116/kurort2016353-55</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Kotenko KV, Kovalev SA, Abuseva GR, et al. Physical and rehabilitation medicine: National guidelines. 2nd ed, revised and expanded. Moscow: GEOTAR-Media; 2023. 912 p. (In Russ.) EDN: STQNKB</mixed-citation><mixed-citation xml:lang="ru">Котенко К.В., Ковалев С.А., Абусева Г.Р., и др. Физическая и реабилитационная медицина: национальное руководство. 2-е изд., перераб. и доп. Москва: ГЭОТАР-Медиа, 2023. 912 с. EDN: STQNKB</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Epifanov VA, Korchazhkina NB. Medical and social rehabilitation of patients with various pathologies. In 2 parts. Part II. Moscow: GEOTAR-Media; 2019. 560 p. (In Russ.) EDN: ULZAFF</mixed-citation><mixed-citation xml:lang="ru">Епифанов В.А., Корчажкина Н.Б. Медико-социальная реабилитация пациентов с различной патологией. В 2-х частях. Часть II. Москва: ГЭОТАР-Медиа, 2019. 560 с. EDN: ULZAFF</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Schwarz A, Schwarz T. Molecular determinants of UV-induced immunosuppression. Exp Dermatol. 2002;11(Suppl. 1):9–12. doi: 10.1034/j.1600-0625.11.s.1.3.x</mixed-citation><mixed-citation xml:lang="ru">Schwarz A., Schwarz T. Molecular determinants of UV-induced immunosuppression // Exp Dermatol. 2002. Vol. 11, Suppl. 1. P. 9–12. doi: 10.1034/j.1600-0625.11.s.1.3.x</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Johnson-Huang LM, Suárez-Fariñas M, Sullivan-Whalen M, et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol. 2010;130(11):2654–2263. doi: 10.1038/jid.2010.166</mixed-citation><mixed-citation xml:lang="ru">Johnson-Huang L.M., Suárez-Fariñas M., Sullivan-Whalen M., et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques // J Invest Dermatol. 2010. Vol. 130, N 11. P. 2654–2263. doi: 10.1038/jid.2010.166</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: Regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol. 1995;104(1):3–6. doi: 10.1111/1523-1747.ep12613446</mixed-citation><mixed-citation xml:lang="ru">Grewe M., Gyufko K., Krutmann J. Interleukin-10 production by cultured human keratinocytes: Regulation by ultraviolet B and ultraviolet A1 radiation // J Invest Dermatol. 1995. Vol. 104, N 1. P. 3–6. doi: 10.1111/1523-1747.ep12613446</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Chekman IS, Syrovaya AO, Makarov VA, et al. Ozone and ozone therapy. No. 1. Kyiv-Kharkov: Tsifrovaya pechat'; 2013. 144 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Чекман И.С., Сыровая А.О., Макаров В.А., и др. Озон и озонотерапия. Вып. 1. Киев-Харьков: Цифрова друкарня, 2013. 144 с.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Chelombitko EG, Gusakova EV. Systemic manifestations of post-Covid syndrome. Russ J Environmental Rehab Med. 2022;(3):48–60. EDN: ODNJGX</mixed-citation><mixed-citation xml:lang="ru">Челомбитько Е.Г., Гусакова Е.В. Системные проявления постковидного синдрома // Russ J Environmental Rehab Med. 2022. № 3. С. 48–60. EDN: ODNJGX</mixed-citation></citation-alternatives></ref></ref-list></back></article>
